Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL | T.CRDL.W.A

Healthcare
Cardiol Therapeutics Inc. (Cardiol) is a Canada-based clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). The Company's lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is in a Phase II/III study in hospitalized patients testing positive... see more

TSX:CRDL - Post Discussion

Cardiol Therapeutics Inc > Canaccord-Genuity Target at $8
View:
Post by Youhillman on Dec 08, 2021 12:09pm

Canaccord-Genuity Target at $8

FYI....another company is providing analyst coverage of Cardiol, that makes 4 that I'm aware of. The highest target price I've seen is $17, this one from CG is the lowest at $8.

Technically the stock became bullish when it went over $2.61 the other day. 

Not a lot of news right now, I guess the next milestone would be the completion of the Covid FDA trials, I believe that was supposed to be in Q4 however that's not looking likely right now.

I'm still long on CRDL!

https://etfdailynews.com/news/cardiol-therapeutics-nasdaqcrdl-coverage-initiated-at-canaccord-genuity/

Comment by NewFanCBD on Dec 10, 2021 8:26pm
I don't mind waiting. I have a funny feeling we're going to hit that $12 mark in 2022. Picked up a few more at this price point. Couldn't resist.
Comment by RusticHit on Dec 30, 2021 12:34pm
Worse Stock  to be in eevry thing moving Up and this is still in Sell off mode after losing 60-70% i think sellers knows whats next  Pr will be ,,,,,,,as always 
Comment by Mapleleaf57 on Jan 10, 2022 12:52pm
where is Newfan now? not pumping it up?  
Cardiol Therapeutics Inc